Breaking News

Dsm-Firmenich Launches Taste Solutions Portfolio for Pharmaceutical Applications

This can help improve drug palatability and accelerate the route to market.

By: Rachel Klemovitch

Assistant Editor

DSM-Firmenich—an innovator in nutrition, health, and beauty—introduced a new portfolio of taste solutions designed for use in pharmaceutical formulations. This offering has been carefully curated for drug developers to address the growing challenges of improving drug palatability and accelerating the route to market.

Jérôme Barra, Vice President Global Marketing Taste, HNC at dsm-Firmenich, commented, “The demand for patient-friendly medications is on the rise, but drug developers face many challenges in masking unpleasant notes and improving the taste of drug products. We’ve unraveled the complex science of designing clean taste profiles to tackle these issues, allowing our customers to focus on effectively bringing their medicines to market.”

The portfolio builds on the company’s history of developing taste solutions across markets, to create safe and effective flavors for drug formulations. Each product has access to a documentation package designed to facilitate the drug approval process.

It encompasses a variety of flavors, extracts, and aromatic compounds, as well as maskers, blockers, and sensates—with solutions designed for use in solid, liquid, or semi-solid dosage forms. 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters